ACADIA Pharmaceuticals Inc.

ACADNASDAQHealthcare● Active

$21.70

+$0.14(+0.65%)

Market Cap$3.7B

P/E Ratio—

52W High$28.35

52W Low$19.69

Avg Volume1.8M

Open$21.70

Beta0.83

Overview

ACADIA Pharmaceuticals Inc. (ACAD) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ACAD · as of Feb 27, 2025

Latest filing snapshot

654

+56+9.36%vs prior year

ACADIA Pharmaceuticals Inc. (ACAD) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global

Total Employees

654

Change (1Y)

+56

Growth % (1Y)

+9.36%

Revenue / Employee

$1.64M

Net Income / Employee

$597.9K

Market Cap

$3.7B

ACAD Employee Count

2004 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2025-02-27	2024-12-31	654	+56	+9.36%
2024-02-28	2023-12-31	598	+85	+16.57%
2023-02-28	2022-12-31	513	-1	-0.19%
2022-03-01	2021-12-31	514	-87	-14.48%
2021-02-25	2020-12-31	601	+98	+19.48%
2020-02-27	2019-12-31	503	+73	+16.98%
2019-02-27	2018-12-31	430	+5	+1.18%
2018-02-27	2017-12-31	425	+55	+14.86%
2017-02-28	2016-12-31	370	+210	+131.25%
2016-02-29	2015-12-31	160	+63	+64.95%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ACADIA Pharmaceuticals Inc.YOU

654$3.7B #3

CRNX

Crinetics Pharmaceuticals, Inc.

Dyne Therapeutics, Inc.

192$2.8B #6

LGND

Ligand Pharmaceuticals Incorporated

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ACAD peer comparison

About ACAD employees

ACAD Employees · Headcount

ACADIA Pharmaceuticals Inc. (ACAD) employee data is sourced from the annual SEC 10-K filing. As of 2024, ACADIA Pharmaceuticals Inc. had 654 full-time employees globally. Full-time employees only. Global consolidated headcount.

ACADIA Pharmaceuticals Inc. employs 654 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $1.64M, reflecting the company's operational efficiency.

ACADIA Pharmaceuticals Inc.'s workforce increased by 56 (9.36%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

ACADIA Pharmaceuticals Inc.'s revenue per employee of $1.64M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

ACAD Employees · 5 questions

As of the latest SEC 10-K filing (2024), ACADIA Pharmaceuticals Inc. had 654 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

ACADIA Pharmaceuticals Inc. employee counthow many employees does ACADIA Pharmaceuticals Inc. haveACAD total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-02-27